2003
Official Establishment of Nanhai Longtime
Pharmaceutical Co., Ltd.
2004
The leading product of Longtime, external recombinant human basic fibroblast growth factor was selected by the National Development and Reform Commission as “National High-tech Industrialization Demonstration Project”
2005
Recombinant human basic fibroblast growth factor Gaifu® launched.
2007
Gaifu® won the first prize of "China Pharmaceutical Association Science and Technology Award".
2008
Gaifu® won the first prize of "Chinese Medical Science and Technology Award". The company was also certified as "Guangdong High-tech Enterprise" for the first time.
2009
Li Xiaokun won the second prize of "National Technical Invention Award" for Gaifu®.
2010
Longtime moved to self-built plant located in No. 96 Taoyuan East Road.
2015
Li Xiaokun won the first prize of "National Science and Technology Progress Award" for the application of the company product in chronic wound. The recombinant human basic fibroblast growth factor for external use solution developed by Longtime’s own was also selected as the "Strategic Emerging Industry Regional Gathering Development Pilot Project" by the National Development and Reform Commission.
2016
"Guangdong Postdoctoral Innovation Practice Base" was established.
2017
Gaifu® won the gold prize of "Invention and Entrepreneurship Award" at the 22nd National Invention Exhibition.
"Guangdong Province Cell Growth Factor Engineering Technology Research Center" was established. "Guangdong Drug Carrier Development Engineering Technology Research Center"was established.
2018
Li Xiaokun won the second prize of "National Science and Technology Progress Award" for new product of growth factor. Gaifu® also won the second prize of "Guangdong Science and Technology".
The company was divided into "Nanhai Longtime Co., LTD." and "Foshan Longtime Health Industry Co., LTD." by means of survival division. The cosmetics workshop of the research Institute was put into operation in Building 2, No. 93, Taoyuan East Road.
2020
The company completed the joint-stock reform and changed its name to "Longtime Biopharmaceutical Co., Ltd."
2021
The new workshop at Building 1 in No.93 Taoyuan East Road passed the GMP compliance inspection.
2022
The new office building was put into use, and the headquarter moved in building 3 No.93 Taoyuan East Road as a whole.
